NeurAxis, Inc.

AMEX:NRXS

Biotechnology

Healthcare
$4.87 +4.25%

+$0.29 today

Market cap
$69.12M
Beta
1.41
P/E (TTM)
-10.5
EPS (TTM)
-$0.67
52W Low $2.20High $9.33

Volume 0.23M

Average 0.18M

NRXS Total Liabilities

Everything the company owes to creditors and other parties.

NeurAxis, Inc.AMEX: NRXS

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities rises 8.2% from a year ago

Total liabilities stood at $3M at the end of Q1 FY2026, up 8.2% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at -24.8% a year.

Context

  • Total liabilities amounted to 34.3% of total assets at the end of Q1 FY2026, down 57.2 pp from a year earlier.
  • Total liabilities increased in 2 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps rising in the next quarterly balance sheet after a +8.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3M-0.2% QoQ
Last fiscal yearDec 2025
$3M+11.7% YoY
Year agoMar 2025
$2.77M+8.2% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.2%——
1 year+11.7%——
3-year CAGR-24.8%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
3M USD
Year-over-year change
+11.7%
4-year CAGR
+17.3%

Total Liabilities vs competitors

How NRXS compares with its peers on the latest reported figures

  • NRXS's Mar 2026 total liabilities of $3M is the lowest of the 4 companies compared; the peer median is $392.05M.
  • Its year-over-year change of +8.2% is the 3rd highest of 4, against a peer median of +9466.9%.
  • Total liabilities amounts to 34.3% of total assets for NRXS, versus a peer median of 16.8%.
NRXS Competitors Peer median
Total Liabilities for NRXS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NERVMinerva Neurosciences, Inc.Jun 2026$296.65B +474318.1%+47.0%312.0%
ENLVEnlivex Therapeutics Ltd.Dec 2025$392.05M +9466.9%+231.1%16.8%
RLYBRallybio CorporationMar 2026$4.2M +7.3%-27.1%7.7%
NRXSNeurAxis, Inc.Mar 2026$3M +8.2%-24.8%34.3%
Peer median (excluding NRXS) $392.05M+9466.9%+47.0%16.8%

Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents320.86K253.7K78.56K3.7M4.97M
Short-term Investments00000
Net Receivables115.3K174.4K73.17K244.62K195.7K
Inventory39.18K48.13K21.22K44.33K257.13K
Other Current Assets072669.66K280.37K70.59K
Total Current Assets491.01K476.96K242.61K4.27M5.73M
Property, Plant & Equipment (Net)245.52K189.39K158.82K374.64K337.13K
Goodwill00000
Intangible Assets23.96K77.56K108.07K96.59K274.78K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0736.74K020.16K58.94K
Total Non-current Assets269.47K1M266.89K491.39K670.85K
Total Assets760.48K1.48M509.5K4.76M6.4M
Account Payables483.79K1.59M1.2M596.95K139.37K
Short-term Debt250.41K489.23K148.06K154.15K148.29K
Tax Payables563777000
Deferred Revenue69.34K59.17K74.95K32.53K28.66K
Other Current Liabilities43.84K4.51M341.7K1.27M2.07M
Total Current Liabilities1.42M6.98M1.89M2.43M2.79M
Long-term Debt51.69K0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities000010K
Total Non-current Liabilities161.29K76.2K27.07K256.5K212.57K
Total Liabilities1.59M7.05M1.91M2.69M3M
Common Stock2.55K1.96K6.51K6.99K10.65K
Retained Earnings(29.15M)(33.93M)(48.56M)(56.8M)(64.6M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(825.66K)(5.57M)(1.4M)2.07M3.4M
Total Debt439.28K598.82K224.26K473.41K416.61K
Net Debt118.42K345.12K145.7K(3.22M)(4.55M)

NeurAxis, Inc.

AMEX:NRXS

Intrinsic Alpha fair value

Locked

Current Price

$4.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.